Carroll Financial Associates’s Ionis Pharmaceuticals IONS Stock Holding History

Carroll Financial Associates’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$24K	Sell	793 -111	-12%	-$3.49K	﹤0.01%	918
2021 Q3	$30K	Buy	904 +21	+2%	+$791	﹤0.01%	883
2021 Q2	$35K	Hold	883	–	–	﹤0.01%	914
2021 Q1	$39K	Buy	883 +90	+11%	+$5.02K	﹤0.01%	826
2020 Q4	$44K	Hold	793	–	–	﹤0.01%	735
2020 Q3	$37K	Hold	793	–	–	﹤0.01%	725
2020 Q2	$46K	Buy	793 +152	+24%	+$8.46K	﹤0.01%	673
2020 Q1	$30K	Hold	641	–	–	﹤0.01%	700
2019 Q4	$38K	Buy	641 +13	+2%	+$775	﹤0.01%	722
2019 Q3	$37K	Sell	628 -164	-21%	-$10.7K	﹤0.01%	682
2019 Q2	$50K	Buy	792 +30	+4%	+$2.12K	﹤0.01%	618
2019 Q1	$61K	Buy	762 +164	+27%	+$10.6K	0.01%	529
2018 Q4	$33K	Hold	598	–	–	﹤0.01%	559
2018 Q3	$30K	Hold	598	–	–	﹤0.01%	606
2018 Q2	$24K	Hold	598	–	–	﹤0.01%	631
2018 Q1	$26K	Buy	598 +500	+510%	+$25.4K	﹤0.01%	605
2017 Q4	$4K	Hold	98	–	–	﹤0.01%	1041
2017 Q3	$5K	Hold	98	–	–	﹤0.01%	977
2017 Q2	$4K	Hold	98	–	–	﹤0.01%	1023
2017 Q1	$3K	Hold	98	–	–	﹤0.01%	1053
2016 Q4	$4K	Hold	98	–	–	﹤0.01%	974
2016 Q3	$3K	Hold	98	–	–	﹤0.01%	1029
2016 Q2	$2K	Hold	98	–	–	﹤0.01%	1050
2016 Q1	$3K	Buy	98 +43	+78%	+$1.75K	﹤0.01%	993
2015 Q4	$3K	Hold	55	–	–	﹤0.01%	949
2015 Q3	$2K	Hold	55	–	–	﹤0.01%	970
2015 Q2	$3K	Buy	55 +24	+77%	+$1.53K	﹤0.01%	933
2015 Q1	$2K	Buy	+31	New	+$2.1K	﹤0.01%	729

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Carroll Financial Associates's IONS Position: Q4 2021 in Review

Carroll Financial Associates reduced its Ionis Pharmaceuticals (IONS) stake by 12% in Q4 2021, selling an estimated $3.49K and leaving 793 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #918.

Carroll Financial Associates first reported a position in IONS in Q1 2015 and has held it in 28 quarters since. The position peaked at $61K in Q1 2019. 341 funds tracked by Wall St. Rank hold IONS as of Q4 2021.

Carroll Financial Associates held 793 shares of Ionis Pharmaceuticals worth $24K as of Q4 2021.
Carroll Financial Associates sold 111 Ionis Pharmaceuticals shares in Q4 2021, an estimated $3.49K.
Ionis Pharmaceuticals made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #918 holding.
Carroll Financial Associates first reported a position in Ionis Pharmaceuticals in Q1 2015 and has held it in 28 quarters since.
Carroll Financial Associates's Ionis Pharmaceuticals position peaked at $61K in Q1 2019.
341 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.